| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |